CoChat

Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

There is a lack of data on how to treat hypertensive patients with diabetes when treatment with medium doses of calcium channel blocker and angiotensin II type 1 receptor blocker (ARB) is insufficient to achieve the target blood pressure (BP). A total of 121 participants with type 2 diabetes and uncontrolled essential hypertension, who were receiving medium doses of amlodipine (5 mg/day) and ARB, were enrolled. Participants were randomized to receive either a high dose of amlodipine (10 mg/day) plus a medium dose of ARB (high-AML) or a medium dose of amlodipine (5 mg/day) plus a high dose of ARB (high-ARB). The depressor effects of these two regimens were monitored using a telemonitoring home BP-measuring system. Fifty-four patients were excluded after an observation period, and the remaining 67 eligible participants were randomized into the two groups; 42 which had a record of their home BP for analysis. The change in morning home systolic and diastolic BP was greater in the high-AML than in the high-ARB (systolic BP; - 7.9 mmHg vs. + 2.7 mmHg; p = 0.0002, diastolic BP; - 3.9 mmHg vs. + 0.6 mmHg; p = 0.0007). In addition, the home systolic and diastolic BP before going to bed and office systolic BP were significantly reduced from week 0 only in the high-AML. An increased dose of amlodipine, but not ARB, reduced home morning BP in hypertensive patients with type 2 diabetes who were already receiving combination therapy with medium doses of amlodipine and ARB.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00380-018-1286-2

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. Okada T, Tanaka H, Kaisei E, Inoue T, Miyoshi H, Ono H, Kuwahara M, Miyake R (2013) Amlodipine10mg/ARB heiyouryouhou to, amlodipine5mg/ARB heiyouryouhou no kouatsukouka no hikakukentou. J Blood Press 20(11):1131–1137 (in Japanese)

Cited by

See all 3

Metadata

Authors
ACADEMIE Study Investigators, Imaizumi, S., Shiga, Y., Ogawa, M., Sako, H., Nagata, Y., Matsunaga, A., Shirotani, T., Hoshino, F., Yahiro, E., Uehara, Y., Morito, N., Tanigawa, H., Shimono, D., Fukushima, M., Sugihara, H., Norimatsu, K., Kusumoto, T., Saku, K., & Miura, S.-I.
Affiliations
Fukuoka University (JP)
Corresponding author
Miura, Shin-ichiro
Venue
Heart and Vessels
Published
2018-11-08
Volume
34
Issue
4
Pages
698-710
ISSN
  • 0910-8327 (ISSN-L)
  • 1615-2573
OpenAlex
W2900052565
Cited by
3
References
41
Citations by year
2022: 1 · 2021: 2
FWCI
0.38
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Heart and Vessels (publishedVersion)
  • PubMed (publishedVersion)
Funders
Dainippon Sumitomo Pharma
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Keywords
type 2 diabetes, essential hypertension, uncontrolled hypertension, amlodipine, calcium channel blockers, angiotensin receptor blockers, adjunctive therapy, blood pressure control, home blood pressure monitoring, remote patient monitoring, combination antihypertensive therapy
MeSH terms
Essential Hypertension, Aged, Blood Pressure, Calcium Channel Blockers, Diabetes Mellitus, Type 2, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Follow-Up Studies, Humans, Male, Treatment Outcome, Amlodipine, Blood Pressure Monitoring, Ambulatory, Angiotensin II Type 1 Receptor Blockers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.